Frequency of hemorrhagic complications in plasmapheresis without extracorporeal circuit anticoagulation, in children

5 páginas

Autores:
Fernández Sarmiento, Jaime
Varela, María A.
Pinzón Flórez, Carlos Eduardo
Tipo de recurso:
Fecha de publicación:
2016
Institución:
Universidad de la Sabana
Repositorio:
Repositorio Universidad de la Sabana
Idioma:
eng
OAI Identifier:
oai:intellectum.unisabana.edu.co:10818/36838
Acceso en línea:
https://www.sciencedirect.com/science/article/pii/S1473050216300210?via%3Dihub
http://hdl.handle.net/10818/36838
Palabra clave:
Plasmapheresis
Apheresis
Therapeutic plasma exchange
Anticoagulation
Rights
License
Attribution-NonCommercial-NoDerivatives 4.0 International
id REPOUSABA2_ec182dc0e570385f12679fa7ce6c9ffa
oai_identifier_str oai:intellectum.unisabana.edu.co:10818/36838
network_acronym_str REPOUSABA2
network_name_str Repositorio Universidad de la Sabana
repository_id_str
spelling Fernández Sarmiento, JaimeVarela, María A.Pinzón Flórez, Carlos Eduardo8/26/2019 9:262019-08-26T14:26:50Z2016https://www.sciencedirect.com/science/article/pii/S1473050216300210?via%3Dihubhttp://hdl.handle.net/10818/3683810.1016/j.transci.2016.05.0025 páginasBackground The current practice of plasmapheresis at most centers employs anticoagulation of the extracorporeal circuit, which has been associated with complications. There are few studies evaluating the efficacy and safety of using plasmapheresis without any anticoagulation. We report our experience using this strategy in children (1 month to 18 years old) over a period of 5 years. Results Two hundred forty-three plasmapheresis sessions without anticoagulation of the extracorporeal circuit, in 27 pediatric patients, were analyzed. Of these, 81.4% were female and the predominant age range was 12–18 years (70.3%). One hundred percent of the patients had PRISM III scale low mortality risk, and the main indication of therapy was acute rejection after renal transplantation (25.9%), followed by recurrence of focal segmental sclerosis in the transplanted kidney (17.2%). Filtration lasted more than 3 hours in 86.8% of cases, with bleeding complications in 2.9% of patients requiring early termination due to associated complications in 3.2% of cases. Other complications were paresthesias (0.41%), vomiting (5%), hypertension during (67.4%) and after therapy (64.6%), and hyperchloremia (46.5%). Conclusions In our experience, plasmapheresis without circuit anticoagulation in children is safe and effective, with a low frequency of bleeding and hydroelectrolytic complications, allowing the achievement of therapeutic goals without altering therapy duration and efficiency. Prospective studies are needed to corroborate these findings.application/pdfengTransfusion and Apheresis ScienceTransfusion and Apheresis Science Volume 55, Issue 1, August 2016, Pages 136-140Attribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/http://purl.org/coar/access_right/c_abf2Universidad de La SabanaIntellectum Repositorio Universidad de La SabanaPlasmapheresisApheresisTherapeutic plasma exchangeAnticoagulationFrequency of hemorrhagic complications in plasmapheresis without extracorporeal circuit anticoagulation, in childrenarticlepublishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8805https://intellectum.unisabana.edu.co/bitstream/10818/36838/2/license_rdf4460e5956bc1d1639be9ae6146a50347MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-8498https://intellectum.unisabana.edu.co/bitstream/10818/36838/3/license.txtf52a2cfd4df262e08e9b300d62c85cabMD5310818/36838oai:intellectum.unisabana.edu.co:10818/368382022-05-10 05:18:44.215Intellectum Universidad de la Sabanacontactointellectum@unisabana.edu.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
dc.title.es_CO.fl_str_mv Frequency of hemorrhagic complications in plasmapheresis without extracorporeal circuit anticoagulation, in children
title Frequency of hemorrhagic complications in plasmapheresis without extracorporeal circuit anticoagulation, in children
spellingShingle Frequency of hemorrhagic complications in plasmapheresis without extracorporeal circuit anticoagulation, in children
Plasmapheresis
Apheresis
Therapeutic plasma exchange
Anticoagulation
title_short Frequency of hemorrhagic complications in plasmapheresis without extracorporeal circuit anticoagulation, in children
title_full Frequency of hemorrhagic complications in plasmapheresis without extracorporeal circuit anticoagulation, in children
title_fullStr Frequency of hemorrhagic complications in plasmapheresis without extracorporeal circuit anticoagulation, in children
title_full_unstemmed Frequency of hemorrhagic complications in plasmapheresis without extracorporeal circuit anticoagulation, in children
title_sort Frequency of hemorrhagic complications in plasmapheresis without extracorporeal circuit anticoagulation, in children
dc.creator.fl_str_mv Fernández Sarmiento, Jaime
Varela, María A.
Pinzón Flórez, Carlos Eduardo
dc.contributor.author.none.fl_str_mv Fernández Sarmiento, Jaime
Varela, María A.
Pinzón Flórez, Carlos Eduardo
dc.subject.es_CO.fl_str_mv Plasmapheresis
Apheresis
Therapeutic plasma exchange
Anticoagulation
topic Plasmapheresis
Apheresis
Therapeutic plasma exchange
Anticoagulation
description 5 páginas
publishDate 2016
dc.date.issued.none.fl_str_mv 2016
dc.date.available.none.fl_str_mv 2019-08-26T14:26:50Z
dc.date.accessioned.none.fl_str_mv 8/26/2019 9:26
dc.type.en.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.hasVersion.es_CO.fl_str_mv publishedVersion
dc.identifier.other.none.fl_str_mv https://www.sciencedirect.com/science/article/pii/S1473050216300210?via%3Dihub
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/10818/36838
dc.identifier.doi.none.fl_str_mv 10.1016/j.transci.2016.05.002
url https://www.sciencedirect.com/science/article/pii/S1473050216300210?via%3Dihub
http://hdl.handle.net/10818/36838
identifier_str_mv 10.1016/j.transci.2016.05.002
dc.language.iso.es_CO.fl_str_mv eng
language eng
dc.relation.ispartofseries.none.fl_str_mv Transfusion and Apheresis Science Volume 55, Issue 1, August 2016, Pages 136-140
dc.rights.*.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
http://purl.org/coar/access_right/c_abf2
dc.format.es_CO.fl_str_mv application/pdf
dc.publisher.es_CO.fl_str_mv Transfusion and Apheresis Science
dc.source.es_CO.fl_str_mv Universidad de La Sabana
Intellectum Repositorio Universidad de La Sabana
institution Universidad de la Sabana
bitstream.url.fl_str_mv https://intellectum.unisabana.edu.co/bitstream/10818/36838/2/license_rdf
https://intellectum.unisabana.edu.co/bitstream/10818/36838/3/license.txt
bitstream.checksum.fl_str_mv 4460e5956bc1d1639be9ae6146a50347
f52a2cfd4df262e08e9b300d62c85cab
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Intellectum Universidad de la Sabana
repository.mail.fl_str_mv contactointellectum@unisabana.edu.co
_version_ 1811952266036379648